Open access peer-reviewed chapter

Pyrazole Scaffold: Strategies toward the Synthesis and Their Applications

Written By

Deweshri Nandurkar, Kishor Danao, Vijayshri Rokde, Ruchi Shivhare and Ujwala Mahajan

Submitted: 27 September 2022 Reviewed: 25 October 2022 Published: 23 November 2022

DOI: 10.5772/intechopen.108764

From the Edited Volume

Strategies for the Synthesis of Heterocycles and Their Applications

Edited by Premlata Kumari and Amit B. Patel

Chapter metrics overview

223 Chapter Downloads

View Full Metrics

Abstract

Pyrazoles have a wide range of applications in medicinal chemistry, drug discovery, agrochemistry, coordination chemistry, and organometallic chemistry. Their popularity has skyrocketed since the early 1990s. Basically, Pyrazole (C3H3N2H) is a simple doubly unsaturated five membered heterocyclic aromatic ring molecule comprising two nitrogen (N) atoms at positions 1- and 2- and three carbon (C) atoms. Pyrazole nucleus is synthesized with various strategies such as multicomponent approach, dipolar cycloadditions, cyclocondensation of hydrazine with carbonyl system, using heterocyclic system and multicomponent approach. A special emphasis is placed on a thorough examination of response processes. Furthermore, the reasons for the increasing popularity of pyrazoles in several fields of science are examined. Pyrazoles have recently been the focus of many techniques, mostly because of how frequently they are used as scaffolds in the synthesis of bioactive chemicals and reactions in various media. The goal of this chapter is to discuss the current developments in synthetic techniques and biological activity related to pyrazole derivatives. The many pharmacological functions of the pyrazole moiety and different synthesis techniques were discussed. This chapter has summarized novel strategies and wide applications of pyrazole scaffold.

Keywords

  • Pyrazole
  • scaffold
  • synthesis
  • application
  • green synthesis
  • microwave

1. Introduction

Ludwig Knorr coined the term “Pyrazole” in 1883. A 5-membered ring structure made up of three carbon atoms and two nitrogen atoms in close proximity defines the family of simple aromatic ring organic compounds known as Pyrazoles. These compounds belong to the heterocyclic series. Although being rarely in nature, they are categorized as alkaloids due to their structure and pharmacological effects on humans. Watermelon seeds yielded the first natural Pyrazole, 1-Pyrazolyl-alanine, in 1959 [1, 2]. Pyrazole refers to both an unsaturated parent chemical and a family of simple aromatic ring organic compounds of the heterocyclic diazole series, which are distinguished by a 5-member ring structure made up of two nitrogen atoms in the neighboring position and three carbon atoms in the central position (Figure 1). Pyrazoles have tautomerism because of the moving C-N double bond inside the heterocycle [3, 4]. Pyrazole’s 1H-tautomer is known as 1H-pyrazole [5]. It is a base of a pyrazolium conjugate. It is an acid conjugate of pyrazol-1-ide. It is a tautomer of the 3H and 4H Pyrazoles (Table 1).

Figure 1.

Structure of Pyrazole.

Molecular FormulaC3H4N2
IUPAC name1H-pyrazole
Molecular Weight68.08
CompositionC (52.93%) H (5.92%) N (41.15%)
Boiling Point187°C
Melting Point68°C
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Dissociation Constants (pKa)2.48 (at 25°C)
Molar Refractivity18.77 ± 0.3 cm3
Molar Volume60.9 ± 3.0 cm3
Parachor161.0 ± 4.0 cm3
Index of Refraction1.528 ± 0.02
Surface Tension48.6 ± 3.0 dyne/cm
Dielectric ConstantNot available
Polarizability7.44 ± 0.5 10-24 cm3
Monoisotopic68.037448 Da
Nominal Mass68 Da

Table 1.

Chemistry and properties of Pyrazole [6].

Two techniques have been used to synthesize substituted Pyrazoles (Figure 2):

  1. Cyclocondensation of hydrazines with 1,3-dicarbonyl compounds or their synthetic 1,3-dielectrophilic equivalents and

  2. Cycloaddition of 1,3-dipoles to dipolarophiles

Figure 2.

Traditional methods for synthesizing Pyrazoles are shown in scheme (a) cyclocondensation; cycloaddition (b) [7].

Recently, new methods such multicomponent one-pot procedures, photoredox reactions, and transition-metal catalyzed reactions have been added to these two standard tactics to improve them. In this part, cyclocondensation will be covered first, then cycloaddition [7].

As [NN] synthons, substituted or unsubstituted hydrazines are easily accessible for the production of pyrazole derivatives. When hydrazines react with 1,3-dielectrophilic compounds like 1,3-dicarbonyl or with structures which are carbonyl, such as enones, ynones, and vinyl ketones possessing a leaving group, pyrazole molecules can be produced [8]. Hydrazines and comparable synthetic equivalents can efficiently condense to form substituted pyrazoles from 1,3-diketones, β-ketoesters, 2,4-diketoesters, and related compounds. The 1, 3-diketone and the appropriate hydrazine were cyclocondensed to create a series of powerful carbonic anhydrase, α-glycosidase, and cholinesterase enzyme inhibitors 1 [9]. Wang and co-workers reported a moderate and acid-free condensation of 1,3-diketones with substituted hydrazines to produce the 1,3,5-trisubstituted and completely substituted Pyrazoles [10]. Hydrazines and α-enones can be combined to produce pyrazolines, which can then be oxidized to produce the equivalent Pyrazoles. Iodine was used by Zhang et al. to mediate the creation of oxidative intramolecular C-N bonds, and the intermediate hydrazones were then cycled to produce Pyrazoles [11]. Ding et al. also described an air-promoted photoredox cyclization of substituted hydrazines with activated alkene (Michael addition reaction acceptors) to produce the corresponding Pyrazoles with good to outstanding yields [12]. Harigae et al. reported synthesizing 3,5-disubstituted pyrazoles in one pot with good yields using a regioselective method [13]. 3,5-disubstituted 1H-pyrazoles were also produced using propargylic alcohols, the reduced form of ynones [14]. According to Guo et al., β-amino vinyl ketone may cyclize with tosyl hydrazine in water to produce completely substituted pyrazoles when iodine and tert-butyl hydroperoxide (TBHP) were introduced [15].

1,3-dipolar cycloaddition plays a significant role in creating substituted Pyrazoles due to its inherent high regioselectivity and efficiency [16]. As a departing group, bromine works well. In order to create 3,5-diaryl-4-bromopyrazoles, Sha et al. used gemdibromoalkene as the substrate and devised a straightforward, highly effective, and regioselective approach [17]. Li and colleagues described a cycloaddition of dicarboxylic alkynes and hydrazines that was catalyzed by rhodium [18]. Kobayashi et al. proposed a one-pot, multicomponent method for creating multisubstituted Pyrazoles starting with primary alcohols [19]. In order to assemble monosubstituted Pyrazoles, Yi et al. reported a brand-new silver-mediated [3 + 2] cycloaddition of alkynes and N-isocyanoiminotriphenylphosphorane (NIITP) [20]. Aldehyde hydrazones and maleimides were combined in a moderate reaction by Zhu et al. that used CuCl as a catalyst to produce dihydropyrazoles [21].

All of the [NN] pieces in each of the pyrazole synthesis methods discussed above were derived from azo compounds or hydrazine derivatives. Recent research by Pearce and colleagues describes an unique fragment combination mode [NC] + [CC] + [N] that produces multi-substituted Pyrazoles [22].

The numerous pharmaceutical uses of Pyrazoles have sped up the methodological advancement of pyrazole synthesis. Many general and practical methods, such as the use of transition-metal catalysts, photoredox reactions, one-pot multicomponent processes, new reactants, and novel reaction types, have resulted in fruitful advancements in the fields of the synthesis and functionalization of pyrazole derivatives over the past ten years [7]. A number of noteworthy biological properties of this molecule include those that are antibacterial, anti-inflammatory, anti-cancer, analgesic, anticonvulsant, anthelmintic, antioxidant, and herbicidal. Considering that Pyrazoles are heterocyclic planar five-membered rings, the research suggests that they have a variety of pharmacological effects [4].

1.1 Strategies for pyrazole synthesis

Pyrazoles are the five-membered heterocycles that constitutes several derivatives or compounds which are useful in various fields like drugs, dyes and in organic synthesis. In this section we represents description and discussion on most of the synthetic methods or strategies of pyrazole heterocyclic system.

There are various routes for pyrazole nucleus synthesis which is described as below:

  1. Multicomponent approach

  2. Dipolar cycloadditions

  3. Cyclocondensation of hydrazine with carbonyl system

  4. Heterocyclic system

1.2 Multicomponent approach

The multicomponent approach is used for synthesis of pyrazole nucleus by performing one pot synthesis reaction to get high yield of product.

1.2.1 In situ formation of carbonyl derivatives

The 3,5-substituted pyrazole derivatives 4 can be synthesized in good yield by the treatment of terminal alkynes 1 with aromatic aldehyde, molecular iodine and hydrazines. It is a very simple and practical method for the preparation of 3,5-substituted pyrazole [13].

The 1,3,5-substituted pyrazoles 6 was prepared by palladocatalyzed carbonylation of acetylenic acids on aryl iodides 5 in the presence of hexacarbonyl molybdenum with excellent yield [23].

1.2.2 In situ formation of β-Aminoenones

The β-Aminoenones synthesized by via coupling between alkyne 8 and an oxime 7 in dimethylformamide which was transformed into pyrazoles 10 with the addition of hydrazine in one pot procedure in good yield [24].

1.2.3 In situ formation of a Hydrazone

It is a novel reaction in which the cyclization of diethyl oxalate 12 with the dianions of hydrazones 11 afforded the pyrazole-3-carboxylates 13 in good yields [25].

The condensation of hydrazine in the presence of phosphorus oxychloride gives the 4-formyl pyrazole 15 which is called as Vilsmeier-Haack reaction [26].

1.2.4 In situ formation of diazo compounds

The Aggarwal team has developed a multicomponent process in which diazo 17 derivatives are generated in situ from various aldehydes 16 and tosylhydrazines, thus limiting the risks associated with the isolation of these compounds. These are then used in a 1,3-dipolar cycloaddition reaction to give corresponding pyrazoles 18 and 19 Diazo compounds derived from aldehydes were reacted with terminal alkynes to furnish regioselectively 3,5-disubstituted pyrazoles in 24–67% yields [27].

1.2.5 Ring opening reaction

A palladium-catalyzed ring opening reaction of 2H-azirines with hydrazones provides polysubstituted pyrazoles 23 with a wide substrate scope [28].

1.2.6 Multicomponent reaction

Pyrazole or isoxazole derivatives 27 are prepared by a palladium-catalyzed four-component coupling of a terminal alkyne 24, hydrazine 25 (hydroxylamine), carbon monoxide under ambient pressure, and an aryl iodide 26 [29].

1.3 Dipolar cycloadditions

In this method the pyrazole nucleus was synthesized by the cycloaddition between an alkyne and 1,3-dipolar compounds such as diazo compounds.

1.3.1 Cycloaddition of Diazocarbonyl compounds

The action of ethyl diazoacetate 29 on phenylpropargyl 28 in triethylamine and in the presence of zinc triflate as a catalyst; the 1,3-dipolar cycloaddition reaction, leads to the corresponding pyrazole 30 in good yield (89%) [30].

1.3.2 Cycloaddition of ethyl diazoacetate

A facile one-pot procedure for the synthesis of pyrazole-5-carboxylates 31 by 1,3-dipolar cycloaddition of ethyl diazoacetate 32 with methylene carbonyl compounds utilizing 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as base and acetonitrile as solvent [31].

1.3.3 Cycloaddition of acetylides with diazocarbonyl compounds

A direct and efficient access towards 3-acylpyrazoles 36 that involves the copper-promoted cycloaddition of acetylides 35 with diazocarbonyl compounds under mild conditions. A wide variety of substituents is tolerated at both the acetylide and the diazo compound [32].

1.3.4 The syndones

The pyrazoles can be obtained by a cycloaddition reaction of sydnones. The synthesis of a trisubstituted pyrazole 39, by 1,3-dipolar cycloaddition of arylsydnones and unsaturated ketone in dry xylene [33].

1.3.5 Cycloaddition of N-isocyanoiminotriphenylphosphorane

A silver-mediated [3 + 2] cycloaddition of N-isocyanoiminotriphenylphosphorane as “CNN” building block to terminal alkynes provides pyrazoles 42. N isocyanoiminotriphenylphosphorane is a stable, safe, easy-to-handle, and odorless solid isocyanide 41. The reaction offers mild conditions, broad substrate scope, and excellent functional group tolerance [20].

1.3.6 Cycloaddition reaction of dialkyl azodicarboxylates

A phosphine-free [3 + 2] cycloaddition reaction of dialkyl azodicarboxylates 44 with substituted propargylamines 43 provides functionalized pyrazoles 45 in good yields and high selectivity at room temperature [34].

1.3.7 Cycloaddition of diazo compounds and alkynyl bromides

A simple, highly efficient, 1,3-dipolar cycloaddition of diazo compounds 46 and alkynyl bromides 47 gives 3,5-diaryl-4-bromo-3H-pyrazoles 48 or the isomerization products 3,5-diaryl-4-bromo-1H-pyrazoles 49 in good yields. The diazo compounds and alkynyl bromides were generated in situ from tosylhydrazones and gem-dibromoalkenes, respectively. The reaction system exhibited high regioselectivity and good functional group tolerance [35].

1.3.8 Cycloaddition of diazoacetonitrile and nitroolefins

A transition-metal-free [3 + 2] cycloaddition reaction between diazoacetonitrile 51 and nitroolefins 50 provides multisubstituted cyanopyrazoles 52. This protocol offers mild reaction conditions, broad substrate scope, good yields, and regioselectivities. A one-pot three-component reaction of nitroolefins with diazoacetonitrile and alkyl halides also provides multisubstituted cyanopyrazoles in good to high yields [36].

1.3.9 Cyclocondensation of hydrazine with carbonyl system

This is a leading method used for obtaining substituted pyrazoles is a cyclocondensation reaction between an appropriate hydrazine acting as a bidentate nucleophile and a carbon unit like a 1,3-dicarbonyl compound, a 1,3-dicarbonyl derivatives or an unsaturated ketone.

1.3.10 From 1,3-diketones

The cyclocondensation of the 1,3-dicarbonyl compounds 53 with the hydrazine derivatives is a simple and rapid approach to obtain polysubstituted pyrazoles 54 and 55. The first synthesis of the substituted pyrazoles was carried out in 1883 by Knorr et al. [11] who reacted diketone with hydrazine derivatives to give two regioisomers [37].

The condensation of phenylhydrazine 57 with the trifluoromethyl)-1,3-diketone 56 in ethanol, affording 1,3,4,5-substituted pyrazole in good yield (63%) [38].

1.3.11 From Acetylenic ketones

The cyclocondensation reaction of hydrazine derivatives 60 on acetylenic ketones 59 to form pyrazoles. The reaction between hydrazine derivatives and acetylenic ketones forms pyrazoles and the reaction again results in a mixture of two regioisomers 61 and 62 [39].

The cyclocondensation of acetylenic ketones 63 on methylhydrazine or aryl hydrazines 64 in ethanol, which provides two difficultly separable regioisomeric pyrazoles 65 and 66 [40].

1.3.12 From vinyl ketones

The cyclocondensation reaction between an ethylenic ketone and a hydrazine derivative results in the synthesis of pyrazolines which, after oxidation, provide the pyrazole ring.

The condensation of an ethylenic ketone 67 with p-(4-(tert-butyl)phenyl) hydrazine 68 in the presence of copper triflate and 1-butyl-3-methylimidazolium hexafluorophosphate bmim] (PF6) as catalysts, to access pyrazoline 69. The corresponding 1,3,5-trisubstituted pyrazole was obtained after oxidation in situ of this pyrazoline [41].

Cyclocondensation of the ethylenic ketone 70 with phenylhydrazine (1.2 eq.) in acetic acid and in the presence of iodine (1.0 eq.) afforded the corresponding pyrazole 71 in good yield (70%) [42].

1.4 From heterocyclic system

1.4.1 From imidazole

Cycloaddition of (5Z)-1-acyl-5-(cyanomethylidene)-3-methylimidazolidine-2,4-diones 72 with arylhydrazonyl chloride under basic conditions to give pyrazole-5-carboxamides 73 in moderate 27–40% yields [43].

1.4.2 From oxazole

5-Trifluoromethyl-3-hydroxypyrazoles 75 were obtained in good yield (46–95%) by heating phenylhydrazine and 4-trifluoroacetyl-1,3-oxazolium-5-olates 74 under reflux of benzene [44].

1.4.3 From pyrimidine

The reaction of nitropyrimidine 76 with arylhydrazines in methanol at room temperature, to afford 4-nitro-3,5-diaminopyrazoles 77 in yields of 21–61% [45].

1.4.4 From Tetrazole

Tetrazolyl acroleins 78 reacts with fumaronitrile in xylene at 140°C to give the corresponding pyrazole formation 79 [46].

Advertisement

2. Applications of pyrazole scaffold

Pyrazole moiety have wide applications and are effective therapeutic scaffolds that display a wide range of biological actions as listed in Figure 3.

Figure 3.

Biological activity of pyrazole moiety.

The synthesis of a novel, powerful family of 5-reductase and aromatase inhibitors derived from 1, 2, 3-triazole derivative uses pyrazole-4-carbaldehyde as the starting material. The appropriate Schiff bases were created by condensation of the starting material with active methylene and various amino pyrazoles. In contrast, starting material was treated in a single pot with ethyl cyanoacetate and thiourea to produce pyrazolo-6-thioxopyridin-2-[3H]-one. Additionally, beginning chemical was reacted with p-methoxy acetophenone, which then reacted with each of the ethyl cyanoacetates to create an unsaturated chalcone derivative. The following derivatives showed 5-α reductase inhibitor and aromatase inhibitor activity prominently compared to reference drug. It is due to the pyridine moiety was present and it was connected to the pyrazoline and 1, 2, 3-trizole moieties (Figure 4) [47].

Figure 4.

Potent derivative showing 5- α reductase inhibitor activity.

Sequence of pyrazolinyl and pyrazolyl pregnenolones were produced and their ability for both series to inhibit 5- α reductase was examined by multiple step synthesis and pregnenolone used as starting material. Cyclization reaction was found to be main step in this synthesis. Derivatives 4b, 4c and 6b were found to be more active for this activity as it contains fluoro group and para position chloro group. 4b and 4c contain Ar ring as follows (Figures 5 and 6) [48].

Figure 5.

Potent compound of pyrazolinyl pregnenolone.

Figure 6.

6b derivatives of pyrazolyl pregnenolone.

Khalillulha H et al. synthesized pyrazole derivatives covering 1, 4-dioxane ring which have low-molecular-weight molecules that are simple to manufacture. On the other hand, silybin is a complicated, highly molecular substance that is difficult to manufacture. In addition, the substances are anticipated to be easily metabolizable, in contrast to silybin, which is straightforward and has a low molecular weight. These derivatives were prepared by Claisen–Schmidt condensation reaction using substituted acetophenone chalcones. Rats’ liver damage caused by CCl4 was used in a hepatotoxicity investigation (Figure 7) [49].

Figure 7.

Pyrazoline derivative.

MAO enzyme having EC number 1.4.3.4 that contain flavin Hence inhibitory activity was done by different researchers like Chimenti F et al. synthesized 1-Thiocarbamoyl-3, 5-diaryl-4, 5-dihydro-(1H) - pyrazole Derivatives by using chalcones, thiosemicarbazide with potassium hydroxide in ethanol as solvent. Its isomers were also tested for MAO inhibitory action. Substrate used was kynuramine. Derivative containing following group those are highly active for MAO inhibition. To check bonding affinity for MAO computational methods were also carried out. Following derivative shows potent activity (Figure 8) [50].

Figure 8.

Pyrazole derivatives.

Secci D prepared pyrazole derivatives are produced either by intermolecular [3 + 2] cycloadditions of 1, 3-dipoles to alkynes excellent inhibitory effect primarily against MAO-B contain halo group when placed in the para position of the aryl group (Figure 9) [51].

Figure 9.

Cycloaddition derivative.

Alam MS et al. used schiff base ligand 4-amino-1, 5-dimethyl-2-phenylpyrazole-3-one with benzaldehyde to form single crystal which was checked by X-ray diffraction analysis. For detection of antioxidant activity they used DPPH Radical Scavenging Activity assayed by Blois method (Figure 10) [52].

Figure 10.

Pyrazole Schiff base derivative.

Gressleri, A et al. prepared derivatives by refluxing for 24 hours with the use of 1, 5-diarylpenta-1, 4-dien-3-ones, aminoguanidine hydrochloride, triethylamine, and ethanol. For antioxidant activity DPPH was used and the color of the DPPH shifts from violet to yellow. From all the synthesized derivatives 1-carboxyamidino-1H-pyrazole derivatives showed potent activity. [53] Hanam A et al. made an effort to produce new heterocycles, 2-cyano-3-(1,3-diphenyl-1H-pyrazol-4-yl) acryloyl chloride was subjected to reactions with various mono-, 1,2-, 1,3-,1,4-, and 1,5-binucleophiles. Assay was performed by using ABTS [2, 20 -azinobis-(3-ethylbenzthiazoline-6-sulphonic acid)] method. In that comparison was done by ascorbic acid as standard (Figure 11) [54, 55].

Figure 11.

Structure of tetrazine.

Alsayari A, et al. prepared pyrazole derivatives by A sulforhodamine B assay method which was used to assess the antiproliferative effects on cancer cell lines were identified: hepatocellular carcinoma (HepG2), colorectal carcinoma (HCT-116), and breast cancer (MCF-7). These are effective xanthine oxidase inhibitory action (IC50 0.83 M) and a high IC50 against the human colon cancer cell line (Figure 12) [56].

Figure 12.

Pyrazole derivative as anticancer.

Different anticancer activity showing in pyrazole moiety were listed here, the preclinical or early-phase clinical trials for these described drugs were passed (Figure 13) [57].

Figure 13.

Pyrazole derivative in preclinical study.

Three different breast cancer cell lines, such as MDA-MB-231, MCF-7, and 4 T1, all were used by authors for breast cancer cell line study as well as HepG2 liver cancer cells, were used to test the cytotoxicity of pyrazole. Synthesized pyrazole 13 derivative (5-oxo-N′-(2-oxoindolin-3-ylidene)-3-phenyl-4,5-dihydro-1H-pyrazole-1-carbothiohydrazide), mechanism was discussed as caused 4 T1 cells to die by preventing wound healing and colony formation, delaying the G0/G1 phase of the cell cycle, activating p27 levels, and most likely inducing apoptosis through DNA intercalation. IC50 value of this synthesized derivative was found to be 25 ± 0.4 μm (Figure 14) [58].

Figure 14.

Pyrazole 13 derivative.

Human lung carcinoma A549 cells, murine P388 leukemia cells, and human ovarian adenocarcinoma A2780 cells were all tested with pyrazole derivatives by synthesizing this derivatives 2-pyridinyl moiety containing compound 12 is mostly active as shown below (Figure 15) [59].

Figure 15.

Pyrazole 12 derivative.

Cyclin-dependent kinases (CDKs), a subfamily of the protein kinase which control the cell cycle. Given that cyclin E is selective for CDK2 and the dysregulation of particular cancer types, CDK2 is an alluring target for malignancies with particular genotypes. According to the ongoing clinical trials, CDKs inhibitor, specifically CDK2/cyclin A-E, has the potential to be a reliable cancer target. The majority of the pyrazole scaffolds have demonstrated CDK2 inhibitor selectivity and potency [60, 61]. The antibacterial activity of a series of 1H-pyrazole-3-carboxylic acid derivatives against Bacillus cereus, Staphylococcus aureus, Escherichia coli, and Pseudomonas putida were assessed by Akbas et al. Having antibacterial action against both Gram-positive and Gram-negative bacteria, the results revealed that compound 5c was the best compound in the series (Figure 16) [62].

Figure 16.

5C (Pyrazole carboxylate derivative).

For the detection of pyrazole pesticides such as fibronil in water samples of environment, method solid-phase extraction (SPE) approach combining with high-performance liquid chromatography as adsorbent multi-walled carbon nanotubes was developed by Ma Jiping et al. [63] (Figure 17).

Figure 17.

Fipronil.

An essential scaffold is 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carbohydrazide, which is produced by Wang Y et al. as an insecticidal compounds. By using species Helicoverpa armigera and Plutella xylostella as standard tebufenozide. Fluoro group containing compound showed potent activity at fourth position and decreased by iodo group [64] (Figure 18).

Figure 18.

Pyrazole derivative.

Advertisement

3. Conclusion

Pyrazole nucleus and its various derivatives have been studied extensively in the past and found to be effective in a variety of pharmacological and pathological conditions. Its structure allows for numerous applications in fields such as technology, medicine, and agriculture. In the agrochemical industry, pyrazole derivatives, in particular, have a long history of use as herbicides, insecticides, fungicides, and acaricides. We have covered a variety of pyrazole-related synthetic strategies and biological applications in this chapter. Even though a wide variety of pyrazole synthesis techniques have been developed by organic chemists, and new techniques are continually being developed, the creation of novel, regioselective pyrazole-forming processes remains an exciting area of study. This chapter serves as a foundation and helps researchers to create novel synthetic approaches and potent new compounds.

References

  1. 1. Eicher T, Hauptmann S, Speicher A. The Chemistry of Heterocycles: Structure, Reactions Synthesis and Applications. 2nd ed. Weinheim: Wiley-VCH; 2003
  2. 2. Alam MJ, Alam O, Alam P, Naim MJ. A review on pyrazole chemical entity and biological activity. International Journal of Pharmaceutical Sciences and Research. 2015;6:1433-1442
  3. 3. Dash B, Karim S. Pyrazoline heterocyclic: A review. International Journal of Pharmaceutical Sciences and Research. 2021;12:2570-2588
  4. 4. Jamwal A, Javed A, Bhardwaj V. A review on Pyrazole derivatives of pharmacological potential. Journal of Pharmaceutical and Biological Sciences. 2013;3:114-123
  5. 5. Dewangan D, Kumar T, Alexander A, Nagori K, Tripathi DK. Pyrazole: Their chemistry and pharmacological potentials: A review. Journal of Current Pharma Research. 2011;1(4):369-374
  6. 6. National Center for Biotechnology Information. PubChem Compound Summary for CID 1048, Pyrazole. 2022. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Pyrazole [Retrieved November 16, 2022]
  7. 7. Li X, Yu Y, Tu Z. Pyrazole scaffold synthesis, functionalization, and applications in Alzheimer’s disease and Parkinson’s disease treatment (2011–2020). Molecules. 2021;26(5):1202
  8. 8. Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot YN, Al-Aizari FA, et al. Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules. 2018;23(1):134
  9. 9. Turkan F, Cetin A, Taslimi P, Gulçin İ. Some pyrazoles derivatives: Potent carbonic anhydrase, α-glycosidase, and cholinesterase enzymes inhibitors. Archiv der Pharmazie. 2018;351(10):1800200
  10. 10. Wang H, Sun X, Zhang S, Liu G, Wang C, Zhu L, et al. Efficient copper-catalyzed synthesis of substituted pyrazoles at room temperature. Synlett. 2018;29(20):2689-2692
  11. 11. Zhang X, Kang J, Niu P, Wu J, Yu W, Chang J. I2 -mediated oxidative C-N bond formation for metal-free one-pot synthesis of di-, tri-, and tetrasubstituted pyrazoles from α,β-unsaturated aldehydes/ketones and hydrazines. The Journal of Organic Chemistry. 2014;79:10170-10178
  12. 12. Ding Y, Zhang T, Chen QY, Zhu C. Visible-light photocatalytic aerobic annulation for the green synthesis of pyrazoles. Organic Letters. 2016;18:4206-4209
  13. 13. Harigae R, Moriyama K, Togo H. Preparation of 3,5-disubstituted pyrazoles and isoxazoles from terminal alkynes, aldehydes, hydrazines, and hydroxylamine. The Journal of Organic Chemistry. 2014;79:2049-2058
  14. 14. Raji Reddy C, Vijaykumar J, Grée R. Facile one-pot synthesis of 3,5-disubstituted 1H-pyrazoles from propargylic alcohols via propargyl hydrazides. Synthesis. 2013;45:830-836
  15. 15. Guo Y, Wang G, Wei L, Wan JP. Domino C-H sulfonylation and pyrazole annulation for fully substituted pyrazole synthesis in water using hydrophilic enaminones. The Journal of Organic Chemistry. 2019;84:2984-2990
  16. 16. Fustero S, Sanchez-Rosello M, Barrio P, Simon-Fuentes A. From 2000 to mid-2010: A fruitful decade for the synthesis of pyrazoles. Chemical Reviews. 2011;111:6984-7034
  17. 17. Sha Q, Wei YY. An efficient one-pot synthesis of 3,5-diaryl-4-bromopyrazoles by 1,3-dipolar cycloaddition of in situ generated diazo compounds and 1-bromoalk-1-ynes. Synthesis. 2013;45:413-420
  18. 18. Li DY, Mao XF, Chen HJ, Chen GR, Liu PN. Rhodium-catalyzed addition-cyclization of hydrazines with alkynes: Pyrazole synthesis via unexpected C-N bond cleavage. Organic Letters. 2014;16:3476-3479
  19. 19. Kobayashi E, Togo H. Facile one-pot transformation of primary alcohols into 3-aryl- and 3-alkyl-isoxazoles and -pyrazoles. Synthesis. 2019;51:3723-3735
  20. 20. Yi F, Zhao W, Wang Z, Bi X. Silver-mediated [3+2] cycloaddition of alkynes and N-isocyanoiminotriphenylphosphorane: Access to monosubstituted pyrazoles. Organic Letters. 2019;21:3158-3161
  21. 21. Zhu JN, Wang WK, Jin ZH, Wang QK, Zhao SY. Pyrrolo[3,4-c]pyrazole synthesis via copper(I) chloride-catalyzed oxidative coupling of hydrazones to maleimides. Organic Letters. 2019;21:5046-5050
  22. 22. Pearce AJ, Harkins RP, Reiner BR, Wotal AC, Dunscomb RJ, Tonks IA. Multicomponent pyrazole synthesis from alkynes, nitriles, and titanium imido complexes via oxidatively induced N-N bond coupling. Journal of the American Chemical Society. 2020;142:4390-4399
  23. 23. Iizuka M, Kondo Y. Palladium-catalyzed Alkynylcarbonylation of aryl iodides with the use of Mo (CO) 6 in the presence of tBu3P ligand. European Journal of Organic Chemistry. 2007;2007:5180-5182
  24. 24. Kovacs S, Novak Z. Copper on iron promoted one-pot synthesis of -aminoenones and 3,5-disubstituted pyrazoles. Tetrahedron. 2013;69:8987-9893
  25. 25. Dang TT, Dang TT, Fischer C, Görls H, Langer P. Synthesis of pyrazole-3-carboxylates and pyrazole-1,5-dicarboxylates by one-pot cyclization of hydrazone dianions with diethyl oxalate. Tetrahedron. 2008;64:2207-2215
  26. 26. Lokhande P, Hasanzadeh K, Konda SG. A novel and efficient approach for the synthesis of new halo substituted 2-arylpyrazolo[4,3-c]coumarin derivatives. European Journal of Chemistry. 2011;2:223-228
  27. 27. Aggarwal VK, de Vicente J, Bonnert RV. A novel one-pot method for the preparation of pyrazoles by 1,3-dipolar cycloadditions of diazo compounds generated in situ. The Journal of Organic Chemistry. 2003;68:5381-5383
  28. 28. Zhang G, Ni H, Chen W, Shao J, Liu H, Chen B, et al. Nickel-catalyzed direct amination of Arenes with Alkylamines. Organic Letters. 2013;15:5967-5969
  29. 29. Ahmed MSM, Kobayashi K, Mori A. One-pot construction of Pyrazoles and Isoxazoles with palladium-catalyzed four-component coupling. Organic Letters. 2005;7:4487-4489
  30. 30. He S, Chen L, Niu Y-N, Wu L-Y, Liang Y-M. 1,3-dipolar cycloaddition of diazoacetate compounds to terminal alkynes promoted by Zn (OTf)2: An efficient way to the preparation of pyrazoles. Tetrahedron Letters. 2009;50:2443-2445
  31. 31. Gioiello A, Khamidullina A, Fulco MC, Venturoni F, Zlotsky S, Pellicciari R. New one-pot synthesis of pyrazole-5-carboxylates by 1,3-dipole cycloadditions of ethyl diazoacetate with _-methylene carbonyl compounds. Tetrahedron Letters. 2009;50:5978-5980
  32. 32. Qi X, Ready JM. Copper-promoted cycloaddition of Diazocarbonyl compounds and Acetylides. Angewandte Chemie, International Edition. 2007;46:3242-3244
  33. 33. Chen F, Liu F-M, Shi H, Chen S-L. A facile access to 1,3,4-trisubstituted pyrazoles via 1,3-dipolar cycloaddition of 3-arylsydnones with ,-unsaturated ketones. Monatshefte für Chemie/Chemical Monthly. 2013;144:879-884
  34. 34. Zhang Y, Liu J, Jia X. Phosphine-free [3+2] cycloaddition of Propargylamines with Dialkyl Azodicarboxylates: An efficient access to Pyrazole backbone. Synthesis. 2018;50:3499-3505
  35. 35. Sha Q, Wei Y. An efficient one-pot synthesis of 3,5-Diaryl-4-bromopyrazoles by 1,3-dipolar cycloaddition of In situ generated diazo compounds and 1-Bromoalk-1-ynes synthesis. Synthesis. 2013;45:413-420
  36. 36. Chen Z, Zhang Y, Nie J, Ma J-A. Transition-metal-free [3 + 2] cycloaddition of Nitroolefins and Diazoacetonitrile: A facile access to multisubstituted Cyanopyrazoles. Organic Letters. 2018;20:2024-2027
  37. 37. Knorr L. Einwirkung von acetessigester auf phenylhydrazin. European Journal of Inorganic Chemistry. 1883;16:2597-2599
  38. 38. Ohtsuka Y, Uraguchi D, Yamamoto K, Tokuhisa K, Yamakawa T. Syntheses of 2-(trifluoromethyl)-1, 3-dicarbonyl compounds through direct trifluoromethylation with CF3I and their application to fluorinated pyrazoles syntheses. Tetrahedron. 2012;68:2636-2649
  39. 39. Moureu C, Delange R. Over some Acetylenketone and over a new method to the synthesis of -Diketones. Bulletin de la Société Chimique de France. 1901;25:302-313
  40. 40. Bishop BC, Brands KM, Gibb AD, Kennedy DJ. Regioselective synthesis of 1,3,5-substituted pyrazoles from acetylenic ketones and hydrazines. Synthesis. 2004;2004:43-52
  41. 41. Rao VK, Tiwari R, Chhikara BS, Shirazi AN, Parang K, Kumar A. Copper triflate-mediated synthesis 1,3,5-triarylpyrazoles in [bmim][PF6] ionic liquid and evaluation of their anticancer activities. RSC Advances. 2013;3:15396-15403
  42. 42. Ponnala S, Prasad SD. Iodine-mediated synthesis of 2-Arylbenzoxazoles, 2-Arylbenzimidazoles, and 1,3,5-Trisubstituted Pyrazoles. Synthetic Communications. 2006;36:2189-2194
  43. 43. Grošelj U, Drobniˇc A, Reˇcnik S, Svete J, Stanovnik B, Golobiˇc A, et al. 1,3-dipolar cycloadditions to (5Z)-1-Acyl-5-(cyanomethylidene)-imidazolidine-2,4-diones: Synthesis and transformations of Spirohydantoin derivatives. Helvetica Chimica Acta. 2001;84:3403-3417
  44. 44. Kawase M, Koiwai H, Yamano A, Miyamae H. Regioselective reaction of mesoionic 4-trifluoroacetyl- 1,3-oxazolium-5-olates and phenylhydrazine: Synthesis of trifluoromethyl substituted pyrazole and 1,2,4-triazine derivatives. Tetrahedron Letters. 1998;39:663-666
  45. 45. Guillard J, Goujon F, Badol P, Poullain D. New synthetic route to diaminonitropyrazoles as precursors of energetic materials. Tetrahedron Letters. 2003;44:5943-5945
  46. 46. Simoni D, Rondanin R, Furnò G, Aiello E, Invidiata FP. Facile synthesis of pyrazoles and pyrroles via thermolysis of tetrazolo[1,5-b]pyridazines, tetrazolo[1,5-a]pyrimidines and tetrazolo [1,5-a]pyridines. Tetrahedron Letters. 2000;41:2699-2703
  47. 47. El-Naggar M, El-All ASA, El-Naem SIA, Abdalla MM, Rashdan HRM. New potent 5α- reductase and aromatase inhibitors derived from 1, 2, 3-Triazole derivative. Molecules. 2020;25(3):672
  48. 48. Banday AH, Shameem SA, Jeelani S. Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: Synthesis and biological evaluation. Steroids. 2014;92:13-19
  49. 49. Khalilullah H, Khan S, Ahsan MJ, Ahmed B. Synthesis and antihepatotoxic activity of 5-(2, 3-dihydro-1, 4-benzodioxane-6-yl)-3-substituted-phenyl-4, 5-dihydro-1H-pyrazole derivatives. Bioorganic & Medical Chemistry Letters. 2011;21(24):7251-7254
  50. 50. Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-Thiocarbamoyl-3, 5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives. Journal of Medicinal Chemistry. 2005;48(23):7113-7122
  51. 51. Secci D, Bolasco A, Chimenti P, Carradori S. The state of the art of Pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents. Current Medicinal Chemistry. 2011;18(33):5114-5144
  52. 52. Alam MS, Lee DU. Synthesis, molecular structure and antioxidant activity of (E)-4-[Benzylideneamino]-1, 5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one, a Schiff Base ligand of 4-Aminoantipyrine. Journal of Chemical Crystallography. 2012;42:93-102
  53. 53. GresslerI A, Moura S, Flores AFC, Flores DC, Colepicolo P. Antioxidant and antimicrobial properties of 2-(4,5- dihydro-1H-pyrazol-1-yl)-pyrimidine and 1-carboxamidino-1H-pyrazole derivatives. Journal of the Brazilian Chemical Society. 2010;21:1477-1483
  54. 54. Sallam HA, Elgubbi AS, El-Helw EAE. Synthesis and antioxidant screening of new 2-cyano-3-(1, 3-diphenyl-1H-pyrazol-4-yl) acryloyl amide derivatives and some pyrazole-based heterocycles. Synthetic Communications. 2020;2020:1-12
  55. 55. Mor S, Khatri M, Punia R, Sindhu S. Recent Progress in anticancer agents incorporating Pyrazole scaffold. Mini Reviews in Medicinal Chemistry. 2022;22(1):115-163
  56. 56. Alsayari A, Asiri YI, Muhsinah AB, Hassan MZ. Anticolon cancer properties of Pyrazole derivatives acting through xanthine oxidase inhibition. Journal of Oncology. 2021;2021:5691982
  57. 57. Simpal K, Paliwal S. Chauhan R synthesis of Pyrazole derivatives possessing anticancer activity: Current status. Synthetic Communications. 2014;44(11):1521-1578
  58. 58. Abdel-Motaal M, El-Senduny FF, Shaaban S. One-pot synthesis and anticancer activity of novel Pyrazole hybrids. Chemistry Select. 2021;6:7306-7316
  59. 59. Balbi A, Anzaldi M, Maccio C, Aiello C, Mazzei M, Gangemi R, et al. Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity. European Journal of Medicinal Chemistry. 2011;2011(46):5293-5309
  60. 60. Shaikh J, Patel K, Khan T. Advances in Pyrazole based scaffold as cyclin-dependent kinase 2 inhibitors for the treatment of cancer. Mini Reviews in Medicinal Chemistry. 2022;22(8):1197-1215
  61. 61. Hafner M, Mills CE, Subramanian K, Chen C, Chung M, Boswell SA, et al. Multiomics profiling establishes the Polypharmacology of FDA-approved CDK4/6 inhibitors and the potential for differential clinical activity. Cell Chemical Biology. 2019;26(8):1067-1080
  62. 62. Akbas E, Berber I, Sener A, Hasanov B. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives. Farmaco. 2005;60:23-26
  63. 63. Ma J, Lu X, Xia Y, Yan F. Determination of pyrazole and pyrrole pesticides in environmental water samples by solid-phase extraction using multi-walled carbon nanotubes as adsorbent coupled with high-performance liquid chromatography. Journal of Chromatographic Science. 2015;53(2):380-384
  64. 64. Wang Y, Xu F, Yu G, et al. Synthesis and insecticidal activity of diacylhydrazine derivatives containing a 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole scaffold. Chemistry Central Journal. 2017;11:50

Written By

Deweshri Nandurkar, Kishor Danao, Vijayshri Rokde, Ruchi Shivhare and Ujwala Mahajan

Submitted: 27 September 2022 Reviewed: 25 October 2022 Published: 23 November 2022